Home › Companies › COLLEGIUM PHARMACEUTICAL INC. › 2023-2024

COLLEGIUM PHARMACEUTICAL INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and COLLEGIUM PHARMACEUTICAL INC.’s Form 8-K, filed May 20, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 28Reported items
  • 260Asset managers
  • 3,185Fund votes
  • May 16, 2024Meeting date

Results at a glance

Meeting of May 16, 2024: 10 items on COLLEGIUM PHARMACEUTICAL INC.’s Form 8-K, filed May 20, 2024: 7 elected · 2 approved · 1 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore COLLEGIUM PHARMACEUTICAL INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by COLLEGIUM PHARMACEUTICAL INC.

These tallies are COLLEGIUM PHARMACEUTICAL INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 20, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

COLLEGIUM PHARMACEUTICAL INC. — official shareholder meeting results, meeting held May 16, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Rita Balice-Gordon 28,105,388568,30524,995 --2,360,841 98%Not verified—
Elect Director: Garen Bohlin 28,404,221268,89925,568 --2,360,841 99.0%Elected—
Elect Director: John Fallon 25,399,4113,273,94925,328 --2,360,841 89%Elected—
Elect Director: John Freund 28,384,244289,46624,978 --2,360,841 99%Elected—
Elect Director: Michael Heffernan 26,121,3292,552,36324,996 --2,360,841 91%Elected—
Elect Director: Neil McFarlane 28,442,938230,76424,986 --2,360,841 99.1%Elected—
Elect Director: Gwen Melincoff 28,081,458592,07625,154 --2,360,841 98%Elected—
Elect Director: Gino Santini 28,284,684389,00025,004 --2,360,841 99%Elected—
2. Approval of, on an advisory basis, the compensation of the Company's named executive officers 28,311,783350,75536,150 --2,360,841 99%Approved—
3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 30,106,21792,25523,996 --837,061 99.6%Approved—

Source: COLLEGIUM PHARMACEUTICAL INC., Form 8-K, filed with the SEC on May 20, 2024 — read the filing on EDGAR.

How asset managers voted at the COLLEGIUM PHARMACEUTICAL INC. 2023-2024 meeting

Each item below shows how the 260 asset managers that disclosed a COLLEGIUM PHARMACEUTICAL INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of COLLEGIUM PHARMACEUTICAL INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John…: Rita Balice-Gordon, Ph.D.

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 66 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Rita Balice-Gordon, Ph.D.

The 66 asset managers below reported 13,551,582 for, 8,840 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 13,551,582AGAINST: 8,840
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Invesco1,252,7230 00For
Principal623,0610 00For
MFS563,1560 00For
State Street538,442159 00For
Dimensional475,9000 00For
Fidelity342,4920 00For
Victory Capital300,8520 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM116,7140 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle89,5660 00For
TIAA87,8480 00For
American Century86,8620 00For
Equitable66,4430 00For
EXCHANGE TRADED CONCEPTS TRUST62,5290 00For
Pacific Life61,5650 00For
WisdomTree57,2360 00For
QUANTITATIVE MASTER SERIES LLC53,3010 00For
BNY Mellon49,8890 00For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

2. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund…: Garen Bohlin

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 65 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Garen Bohlin

The 65 asset managers below reported 10,930,732 for, 97 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,930,732AGAINST: 97
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Invesco1,252,7230 00For
Principal623,0610 00For
MFS563,1560 00For
State Street538,50497 00For
Dimensional475,9000 00For
Fidelity342,4920 00For
Victory Capital300,8520 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM116,7140 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle89,5660 00For
TIAA87,8480 00For
American Century86,8620 00For
Equitable66,4430 00For
EXCHANGE TRADED CONCEPTS TRUST62,5290 00For
Pacific Life61,5650 00For
WisdomTree57,2360 00For
QUANTITATIVE MASTER SERIES LLC53,3010 00For
BNY Mellon49,8890 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC48,8000 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

3. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund…: Gino Santini

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 65 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Gino Santini

The 65 asset managers below reported 10,928,975 for, 1,854 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,928,975AGAINST: 1,854
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Invesco1,252,7230 00For
Principal623,0610 00For
MFS563,1560 00For
State Street538,456145 00For
Dimensional475,9000 00For
Fidelity342,4920 00For
Victory Capital300,8520 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM116,7140 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle89,5660 00For
TIAA87,8480 00For
American Century86,8620 00For
Equitable66,4430 00For
EXCHANGE TRADED CONCEPTS TRUST62,5290 00For
Pacific Life61,5650 00For
WisdomTree57,2360 00For
QUANTITATIVE MASTER SERIES LLC53,3010 00For
BNY Mellon49,8890 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC48,8000 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

4. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund…: Gwen Melincoff

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 65 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Gwen Melincoff

The 65 asset managers below reported 10,921,989 for, 8,840 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,921,989AGAINST: 8,840
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Invesco1,252,7230 00For
Principal623,0610 00For
MFS563,1560 00For
State Street538,442159 00For
Dimensional475,9000 00For
Fidelity342,4920 00For
Victory Capital300,8520 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM116,7140 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle89,5660 00For
TIAA87,8480 00For
American Century86,8620 00For
Equitable66,4430 00For
EXCHANGE TRADED CONCEPTS TRUST62,5290 00For
Pacific Life61,5650 00For
WisdomTree57,2360 00For
QUANTITATIVE MASTER SERIES LLC53,3010 00For
BNY Mellon49,8890 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC48,8000 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

5. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund…: John Fallon M.D.

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

94% of fund votes cast · no official result

FOR
Details: description as filed, votes by 65 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: John Fallon M.D.

The 65 asset managers below reported 10,221,347 for, 709,482 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,221,347AGAINST: 709,482
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Invesco1,252,7230 00For
Principal623,0610 00For
MFS563,1560 00For
State Street909537,692 00Against
Dimensional475,9000 00For
Fidelity342,4920 00For
Victory Capital300,8520 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM116,7140 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle089,566 00Against
TIAA87,8480 00For
American Century86,8620 00For
Equitable66,4430 00For
EXCHANGE TRADED CONCEPTS TRUST62,5290 00For
Pacific Life61,5650 00For
WisdomTree57,2360 00For
QUANTITATIVE MASTER SERIES LLC53,3010 00For
BNY Mellon49,8890 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC48,8000 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

6. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund…: John Freund, M.D.

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 65 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: John Freund, M.D.

The 65 asset managers below reported 10,930,732 for, 97 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,930,732AGAINST: 97
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Invesco1,252,7230 00For
Principal623,0610 00For
MFS563,1560 00For
State Street538,50497 00For
Dimensional475,9000 00For
Fidelity342,4920 00For
Victory Capital300,8520 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM116,7140 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle89,5660 00For
TIAA87,8480 00For
American Century86,8620 00For
Equitable66,4430 00For
EXCHANGE TRADED CONCEPTS TRUST62,5290 00For
Pacific Life61,5650 00For
WisdomTree57,2360 00For
QUANTITATIVE MASTER SERIES LLC53,3010 00For
BNY Mellon49,8890 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC48,8000 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

7. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John…: Michael Heffernan, R.Ph.

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

90% of fund votes cast · no official result

FOR
Details: description as filed, votes by 65 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Michael Heffernan, R.Ph.

The 65 asset managers below reported 9,884,343 for, 1,046,486 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,884,343AGAINST: 1,046,486
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Invesco1,252,7230 00For
Principal623,0610 00For
MFS563,1560 00For
State Street960537,641 00Against
Dimensional0475,900 00Against
Fidelity342,4920 00For
Victory Capital300,8520 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM116,7140 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle89,5660 00For
TIAA87,8480 00For
American Century86,8620 00For
Equitable66,4430 00For
EXCHANGE TRADED CONCEPTS TRUST62,5290 00For
Pacific Life61,5650 00For
WisdomTree57,2360 00For
QUANTITATIVE MASTER SERIES LLC53,3010 00For
BNY Mellon49,8890 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC48,8000 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

8. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund…: Neil F. Mcfarlane

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 65 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Neil F. Mcfarlane

The 65 asset managers below reported 10,930,732 for, 97 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,930,732AGAINST: 97
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Invesco1,252,7230 00For
Principal623,0610 00For
MFS563,1560 00For
State Street538,50497 00For
Dimensional475,9000 00For
Fidelity342,4920 00For
Victory Capital300,8520 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM116,7140 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle89,5660 00For
TIAA87,8480 00For
American Century86,8620 00For
Equitable66,4430 00For
EXCHANGE TRADED CONCEPTS TRUST62,5290 00For
Pacific Life61,5650 00For
WisdomTree57,2360 00For
QUANTITATIVE MASTER SERIES LLC53,3010 00For
BNY Mellon49,8890 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC48,8000 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

9. Election Of Director To Hold Office Until The 2025 Annual Meeting: Joseph Ciaffoni

No official matchDIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FORABSTAIN
Details: votes by 35 asset managers

The 35 asset managers below reported 3,058,648 for, 975,857 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 3,058,648ABSTAIN: 975,857
Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Joseph Ciaffoni” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Pacer Funds Trust1,838,1180 00For
SEI00 421,5120Abstain
Federated Hermes316,3010 00For
Charles Schwab00 313,5300Abstain
FINANCIAL INVESTORS TRUST290,9780 00For
Principal151,4140 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
Prudential/PGIM102,8280 00For
Jackson National00 80,0850Abstain
ADVISORS' INNER CIRCLE FUND00 48,2000Abstain
JPMorgan00 38,1260Abstain
Northern Lights Fund Trust IV22,3880 00For
Allianz00 20,7860Abstain
RBB Fund Trust16,4740 00For
James Alpha Funds Trust16,1120 00For
Global X00 15,8990Abstain
Brighthouse00 14,8850Abstain
Harbor ETF Trust13,6730 00For
Russell Investments12,9050 00For
John Hancock00 12,3720Abstain
ETF Series Solutions7,5590 00For
Bridge Builder Trust00 5,9240Abstain
Investment Managers Series Trust II5,4450 00For
NEW COVENANT FUNDS00 2,9150Abstain

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

10. Elect Director: John Freund

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 28,384,244AGAINST: 289,466
Details: description as filed, official tally, votes by 20 asset managers

Description as filed by funds: Election Of Director To Hold Office Until The 2025 Annual Meeting: John Freund, M.D.

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: John Freund”): 28,384,244 for, 289,466 against, per its Form 8-K filed May 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Michael Heffernan, Neil McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2025 Annual Meeting of Shareholders.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 20 asset managers below reported 2,019,056 for, 14,885 abstained.

FOR
FOR: 2,019,056ABSTAIN: 14,885
Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: John Freund, M.D.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust805,6380 00For
SEI421,5120 00For
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
Prudential/PGIM34,0190 00For
Empower24,8190 00For
James Alpha Funds Trust16,1120 00For
Global X15,8990 00For
Brighthouse00 14,8850Abstain
Russell Investments12,9050 00For
NEW COVENANT FUNDS2,9150 00For
TETON WESTWOOD FUNDS2,7000 00For
Jackson Creek Investment Advisors LLC1,4320 00For
Vericimetry Funds1,1100 00For
SYNTAX ETF TRUST9370 00For
Nationwide5360 00For
Warren Street Wealth Advisors, LLC2550 00For
CORNELL UNIVERSITY2020 00For
Boltwood Capital Management340 00For

11. Elect Director: Michael Heffernan

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 26,121,329AGAINST: 2,552,363
Details: description as filed, official tally, votes by 20 asset managers

Description as filed by funds: Election Of Director To Hold Office Until The 2025 Annual Meeting: Michael Heffernan, R.Ph.

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Michael Heffernan”): 26,121,329 for, 2,552,363 against, per its Form 8-K filed May 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Michael Heffernan, Neil McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2025 Annual Meeting of Shareholders.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 20 asset managers below reported 1,960,218 for, 58,838 against, 14,885 abstained.

FOR
FOR: 1,960,218AGAINST: 58,838ABSTAIN: 14,885
Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Michael Heffernan, R.Ph.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust805,6380 00For
SEI421,5120 00For
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
Prudential/PGIM034,019 00Against
Empower024,819 00Against
James Alpha Funds Trust16,1120 00For
Global X15,8990 00For
Brighthouse00 14,8850Abstain
Russell Investments12,9050 00For
NEW COVENANT FUNDS2,9150 00For
TETON WESTWOOD FUNDS2,7000 00For
Jackson Creek Investment Advisors LLC1,4320 00For
Vericimetry Funds1,1100 00For
SYNTAX ETF TRUST9370 00For
Nationwide5360 00For
Warren Street Wealth Advisors, LLC2550 00For
CORNELL UNIVERSITY2020 00For
Boltwood Capital Management340 00For

12. Elect Director: Rita Balice-Gordon

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 28,105,388AGAINST: 568,305
Details: description as filed, official tally, votes by 19 asset managers

Description as filed by funds: Election Of Director To Hold Office Until The 2025 Annual Meeting: Rita Balice-Gordon, Ph.D.

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Rita Balice-Gordon”): 28,105,388 for, 568,305 against, per its Form 8-K filed May 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 19 asset managers below reported 2,002,944 for, 14,885 abstained.

FOR
FOR: 2,002,944ABSTAIN: 14,885
Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Rita Balice-Gordon, Ph.D.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust805,6380 00For
SEI421,5120 00For
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
Prudential/PGIM34,0190 00For
Empower24,8190 00For
Global X15,8990 00For
Brighthouse00 14,8850Abstain
Russell Investments12,9050 00For
NEW COVENANT FUNDS2,9150 00For
TETON WESTWOOD FUNDS2,7000 00For
Jackson Creek Investment Advisors LLC1,4320 00For
Vericimetry Funds1,1100 00For
SYNTAX ETF TRUST9370 00For
Nationwide5360 00For
Warren Street Wealth Advisors, LLC2550 00For
CORNELL UNIVERSITY2020 00For
Boltwood Capital Management340 00For

13. Elect Director: Garen Bohlin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 28,404,221AGAINST: 268,899
Details: description as filed, official tally, votes by 19 asset managers

Description as filed by funds: Election Of Director To Hold Office Until The 2025 Annual Meeting: Garen Bohlin

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Garen Bohlin”): 28,404,221 for, 268,899 against, per its Form 8-K filed May 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Michael Heffernan, Neil McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2025 Annual Meeting of Shareholders.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 19 asset managers below reported 2,017,946 for, 14,885 abstained.

FOR
FOR: 2,017,946ABSTAIN: 14,885
Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Garen Bohlin” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust805,6380 00For
SEI421,5120 00For
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
Prudential/PGIM34,0190 00For
Empower24,8190 00For
James Alpha Funds Trust16,1120 00For
Global X15,8990 00For
Brighthouse00 14,8850Abstain
Russell Investments12,9050 00For
NEW COVENANT FUNDS2,9150 00For
TETON WESTWOOD FUNDS2,7000 00For
Jackson Creek Investment Advisors LLC1,4320 00For
SYNTAX ETF TRUST9370 00For
Nationwide5360 00For
Warren Street Wealth Advisors, LLC2550 00For
CORNELL UNIVERSITY2020 00For
Boltwood Capital Management340 00For

14. Elect Director: Gino Santini

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 28,284,684AGAINST: 389,000
Details: description as filed, official tally, votes by 19 asset managers

Description as filed by funds: Election Of Director To Hold Office Until The 2025 Annual Meeting: Gino Santini

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Gino Santini”): 28,284,684 for, 389,000 against, per its Form 8-K filed May 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Michael Heffernan, Neil McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2025 Annual Meeting of Shareholders.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 19 asset managers below reported 2,017,946 for, 14,885 abstained.

FOR
FOR: 2,017,946ABSTAIN: 14,885
Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Gino Santini” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust805,6380 00For
SEI421,5120 00For
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
Prudential/PGIM34,0190 00For
Empower24,8190 00For
James Alpha Funds Trust16,1120 00For
Global X15,8990 00For
Brighthouse00 14,8850Abstain
Russell Investments12,9050 00For
NEW COVENANT FUNDS2,9150 00For
TETON WESTWOOD FUNDS2,7000 00For
Jackson Creek Investment Advisors LLC1,4320 00For
SYNTAX ETF TRUST9370 00For
Nationwide5360 00For
Warren Street Wealth Advisors, LLC2550 00For
CORNELL UNIVERSITY2020 00For
Boltwood Capital Management340 00For

15. Elect Director: Gwen Melincoff

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 28,081,458AGAINST: 592,076
Details: description as filed, official tally, votes by 19 asset managers

Description as filed by funds: Election Of Director To Hold Office Until The 2025 Annual Meeting: Gwen Melincoff

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Gwen Melincoff”): 28,081,458 for, 592,076 against, per its Form 8-K filed May 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Michael Heffernan, Neil McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2025 Annual Meeting of Shareholders.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 19 asset managers below reported 2,017,946 for, 14,885 abstained.

FOR
FOR: 2,017,946ABSTAIN: 14,885
Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Gwen Melincoff” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust805,6380 00For
SEI421,5120 00For
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
Prudential/PGIM34,0190 00For
Empower24,8190 00For
James Alpha Funds Trust16,1120 00For
Global X15,8990 00For
Brighthouse00 14,8850Abstain
Russell Investments12,9050 00For
NEW COVENANT FUNDS2,9150 00For
TETON WESTWOOD FUNDS2,7000 00For
Jackson Creek Investment Advisors LLC1,4320 00For
SYNTAX ETF TRUST9370 00For
Nationwide5360 00For
Warren Street Wealth Advisors, LLC2550 00For
CORNELL UNIVERSITY2020 00For
Boltwood Capital Management340 00For

16. Elect Director: John Fallon

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 25,399,411AGAINST: 3,273,949
Details: description as filed, official tally, votes by 19 asset managers

Description as filed by funds: Election Of Director To Hold Office Until The 2025 Annual Meeting: John Fallon M.D.

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: John Fallon”): 25,399,411 for, 3,273,949 against, per its Form 8-K filed May 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Michael Heffernan, Neil McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2025 Annual Meeting of Shareholders.”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 19 asset managers below reported 1,504,601 for, 513,345 against, 14,885 abstained.

FORAGAINST
FOR: 1,504,601AGAINST: 513,345ABSTAIN: 14,885
Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: John Fallon M.D.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust805,6380 00For
SEI0421,512 00Against
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
ADVISORS' INNER CIRCLE FUND048,200 00Against
Prudential/PGIM34,0190 00For
Empower024,819 00Against
James Alpha Funds Trust16,1120 00For
Global X015,899 00Against
Brighthouse00 14,8850Abstain
Russell Investments12,9050 00For
NEW COVENANT FUNDS02,915 00Against
TETON WESTWOOD FUNDS2,7000 00For
Jackson Creek Investment Advisors LLC1,4320 00For
SYNTAX ETF TRUST9370 00For
Nationwide5360 00For
Warren Street Wealth Advisors, LLC2550 00For
CORNELL UNIVERSITY2020 00For
Boltwood Capital Management340 00For

17. Elect Director: Neil McFarlane

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 28,442,938AGAINST: 230,764
Details: description as filed, official tally, votes by 19 asset managers

Description as filed by funds: Election Of Director To Hold Office Until The 2025 Annual Meeting: Neil F. Mcfarlane

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Neil McFarlane”): 28,442,938 for, 230,764 against, per its Form 8-K filed May 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Michael Heffernan, Neil McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2025 Annual Meeting of Shareholders.”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 19 asset managers below reported 2,001,834 for, 16,112 against, 14,885 abstained.

FOR
FOR: 2,001,834AGAINST: 16,112ABSTAIN: 14,885
Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Neil F. Mcfarlane” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust805,6380 00For
SEI421,5120 00For
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
Prudential/PGIM34,0190 00For
Empower24,8190 00For
James Alpha Funds Trust016,112 00Against
Global X15,8990 00For
Brighthouse00 14,8850Abstain
Russell Investments12,9050 00For
NEW COVENANT FUNDS2,9150 00For
TETON WESTWOOD FUNDS2,7000 00For
Jackson Creek Investment Advisors LLC1,4320 00For
SYNTAX ETF TRUST9370 00For
Nationwide5360 00For
Warren Street Wealth Advisors, LLC2550 00For
CORNELL UNIVERSITY2020 00For
Boltwood Capital Management340 00For

18. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil…

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 19 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Garen Bohlin

The 19 asset managers below reported 2,612,365 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,612,365
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Pacer Funds Trust1,838,1180 00For
FINANCIAL INVESTORS TRUST290,9780 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
Jackson National80,0850 00For
JPMorgan38,1260 00For
Northern Lights Fund Trust IV22,3880 00For
Allianz20,7860 00For
RBB Fund Trust16,4740 00For
Harbor ETF Trust13,6730 00For
John Hancock12,3720 00For
ETF Series Solutions7,5590 00For
Bridge Builder Trust5,9240 00For
Investment Managers Series Trust II5,4450 00For
NORTHERN LIGHTS FUND TRUST II2,6510 00For
WILSHIRE MUTUAL FUNDS INC9390 00For
Managed Portfolio Series1040 00For
CITY NATIONAL ROCHDALE FUNDS460 00For
GPS Funds I440 00For

19. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil…

No official matchDIRECTOR ELECTIONS

99.7% of fund votes cast · no official result

FOR
Details: description as filed, votes by 19 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Gino Santini

The 19 asset managers below reported 2,604,806 for, 7,559 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,604,806AGAINST: 7,559
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Pacer Funds Trust1,838,1180 00For
FINANCIAL INVESTORS TRUST290,9780 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
Jackson National80,0850 00For
JPMorgan38,1260 00For
Northern Lights Fund Trust IV22,3880 00For
Allianz20,7860 00For
RBB Fund Trust16,4740 00For
Harbor ETF Trust13,6730 00For
John Hancock12,3720 00For
ETF Series Solutions07,559 00Against
Bridge Builder Trust5,9240 00For
Investment Managers Series Trust II5,4450 00For
NORTHERN LIGHTS FUND TRUST II2,6510 00For
WILSHIRE MUTUAL FUNDS INC9390 00For
Managed Portfolio Series1040 00For
CITY NATIONAL ROCHDALE FUNDS460 00For
GPS Funds I440 00For

20. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil…

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 19 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Gwen Melincoff

The 19 asset managers below reported 2,612,365 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,612,365
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Pacer Funds Trust1,838,1180 00For
FINANCIAL INVESTORS TRUST290,9780 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
Jackson National80,0850 00For
JPMorgan38,1260 00For
Northern Lights Fund Trust IV22,3880 00For
Allianz20,7860 00For
RBB Fund Trust16,4740 00For
Harbor ETF Trust13,6730 00For
John Hancock12,3720 00For
ETF Series Solutions7,5590 00For
Bridge Builder Trust5,9240 00For
Investment Managers Series Trust II5,4450 00For
NORTHERN LIGHTS FUND TRUST II2,6510 00For
WILSHIRE MUTUAL FUNDS INC9390 00For
Managed Portfolio Series1040 00For
CITY NATIONAL ROCHDALE FUNDS460 00For
GPS Funds I440 00For

21. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil…

No official matchDIRECTOR ELECTIONS

99.1% of fund votes cast · no official result

FOR
Details: description as filed, votes by 19 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting John Fallon

The 19 asset managers below reported 2,588,934 for, 23,431 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,588,934AGAINST: 23,431
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Pacer Funds Trust1,838,1180 00For
FINANCIAL INVESTORS TRUST290,9780 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
Jackson National80,0850 00For
JPMorgan38,1260 00For
Northern Lights Fund Trust IV022,388 00Against
Allianz20,7860 00For
RBB Fund Trust16,4740 00For
Harbor ETF Trust13,6730 00For
John Hancock12,3720 00For
ETF Series Solutions7,5590 00For
Bridge Builder Trust5,9240 00For
Investment Managers Series Trust II5,4450 00For
NORTHERN LIGHTS FUND TRUST II2,6510 00For
WILSHIRE MUTUAL FUNDS INC0939 00Against
Managed Portfolio Series0104 00Against
CITY NATIONAL ROCHDALE FUNDS460 00For
GPS Funds I440 00For

22. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil…

No official matchDIRECTOR ELECTIONS

99.1% of fund votes cast · no official result

FOR
Details: description as filed, votes by 19 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting John Freund

The 19 asset managers below reported 2,589,977 for, 22,388 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,589,977AGAINST: 22,388
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Pacer Funds Trust1,838,1180 00For
FINANCIAL INVESTORS TRUST290,9780 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
Jackson National80,0850 00For
JPMorgan38,1260 00For
Northern Lights Fund Trust IV022,388 00Against
Allianz20,7860 00For
RBB Fund Trust16,4740 00For
Harbor ETF Trust13,6730 00For
John Hancock12,3720 00For
ETF Series Solutions7,5590 00For
Bridge Builder Trust5,9240 00For
Investment Managers Series Trust II5,4450 00For
NORTHERN LIGHTS FUND TRUST II2,6510 00For
WILSHIRE MUTUAL FUNDS INC9390 00For
Managed Portfolio Series1040 00For
CITY NATIONAL ROCHDALE FUNDS460 00For
GPS Funds I440 00For

23. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil…

No official matchDIRECTOR ELECTIONS

99.2% of fund votes cast · no official result

FOR
Details: description as filed, votes by 19 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Michael Heffernan

The 19 asset managers below reported 2,591,495 for, 20,870 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,591,495AGAINST: 20,870
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Pacer Funds Trust1,838,1180 00For
FINANCIAL INVESTORS TRUST290,9780 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
Jackson National71,0849,001 00Mixed
JPMorgan38,1260 00For
Northern Lights Fund Trust IV22,3880 00For
Allianz16,4764,310 00Mixed
RBB Fund Trust16,4740 00For
Harbor ETF Trust13,6730 00For
John Hancock12,3720 00For
ETF Series Solutions07,559 00Against
Bridge Builder Trust5,9240 00For
Investment Managers Series Trust II5,4450 00For
NORTHERN LIGHTS FUND TRUST II2,6510 00For
WILSHIRE MUTUAL FUNDS INC9390 00For
Managed Portfolio Series1040 00For
CITY NATIONAL ROCHDALE FUNDS460 00For
GPS Funds I440 00For

24. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil…

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 19 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Neil F. Mcfarlane

The 19 asset managers below reported 2,612,365 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,612,365
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Pacer Funds Trust1,838,1180 00For
FINANCIAL INVESTORS TRUST290,9780 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
Jackson National80,0850 00For
JPMorgan38,1260 00For
Northern Lights Fund Trust IV22,3880 00For
Allianz20,7860 00For
RBB Fund Trust16,4740 00For
Harbor ETF Trust13,6730 00For
John Hancock12,3720 00For
ETF Series Solutions7,5590 00For
Bridge Builder Trust5,9240 00For
Investment Managers Series Trust II5,4450 00For
NORTHERN LIGHTS FUND TRUST II2,6510 00For
WILSHIRE MUTUAL FUNDS INC9390 00For
Managed Portfolio Series1040 00For
CITY NATIONAL ROCHDALE FUNDS460 00For
GPS Funds I440 00For

25. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil…

No official matchDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 19 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Rita Balice- Gordon

The 19 asset managers below reported 2,612,365 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,612,365
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Pacer Funds Trust1,838,1180 00For
FINANCIAL INVESTORS TRUST290,9780 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
Jackson National80,0850 00For
JPMorgan38,1260 00For
Northern Lights Fund Trust IV22,3880 00For
Allianz20,7860 00For
RBB Fund Trust16,4740 00For
Harbor ETF Trust13,6730 00For
John Hancock12,3720 00For
ETF Series Solutions7,5590 00For
Bridge Builder Trust5,9240 00For
Investment Managers Series Trust II5,4450 00For
NORTHERN LIGHTS FUND TRUST II2,6510 00For
WILSHIRE MUTUAL FUNDS INC9390 00For
Managed Portfolio Series1040 00For
CITY NATIONAL ROCHDALE FUNDS460 00For
GPS Funds I440 00For

26. Elect Director Joseph Ciaffoni *Withdrawn Resolution*

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

UNKNOWN
Details: votes by 12 asset managers

The 12 asset managers below reported 255 for, 20,966 abstained, 47,680 not voted, 2,093,812 unknown. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 255ABSTAIN: 20,966UNKNOWN: 2,093,812NOT VOTED: 47,680
Largest asset managers voting on “Elect Director Joseph Ciaffoni *Withdrawn Resolution*” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST00 00--
Capitol Series Trust00 00--
Empower00 00Not Voted
Catholic Responsible Investments Funds00 20,9660Abstain
Lincoln Financial00 00Not Voted
Blackstone Alternative Investment Funds00 00Not Voted
SA FUNDS INVESTMENT TRUST00 00--
Keel Point, LLC00 00Not Voted
Warren Street Wealth Advisors, LLC2550 00For
CORNELL UNIVERSITY00 00--
Humankind Benefit Corp00 00--
WisdomTree00 00--

27. 2. Approval of, on an advisory basis, the compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 28,311,783AGAINST: 350,755
Details: description as filed, official tally, votes by 259 asset managers

Description as filed by funds: Approval of, on an advisory basis, the compensation of the Company's named executive officers.

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“2. Approval of, on an advisory basis, the compensation of the Company's named executive officers”): 28,311,783 for, 350,755 against — passed, per its Form 8-K filed May 20, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “On an advisory basis, the Company's shareholders approved the compensation of the Company's named executive officers.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 97 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Pacer Funds Trust1,838,1180 00For
Invesco1,252,7230 00For
Capitol Series Trust805,6380 00For
Principal623,0610 00For
MFS563,1560 00For
State Street538,6010 00For
Dimensional475,9000 00For
SEI421,5120 00For
Fidelity342,4920 00For
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
Victory Capital300,8520 00For
FINANCIAL INVESTORS TRUST290,9780 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM150,7330 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle89,5660 00For

Fund voting reports, all 97 managers: 18,166,709 for, 22,388 against, 14,885 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 189 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Rubric Capital Management LP1,286,9550 00For
State Street1,222,0900 00For
Invesco947,1510 00For
BlackRock915,8460 00For
PRINCIPAL GLOBAL INVESTORS859,0420 00For
Camber Capital Management LP842,1250 00For
FULLER & THALER ASSET MANAGEMENT, INC.839,1080 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/661,7980 00For
EMERALD MUTUAL FUND ADVISERS TRUST511,2010 00For
Victory Capital500,6360 00For
Janus Henderson488,1010 00For
SEI430,3170 00For
Rock Springs Capital Management LP412,0430 00For
GEODE CAPITAL MANAGEMENT, LLC369,3860 00For
Renaissance359,6530 00For
Charles Schwab330,1110 00For
Man Group plc325,1500 00For
Federated Hermes318,9020 00For
Northern Trust295,77926 00For
EMERALD ADVISERS, LLC272,8080 00For
MELLON INVESTMENTS Corp217,7010 00For
Two Sigma208,4780 00For
Allianz175,5060 00For
South Dakota Investment Council157,7720 00For
DE Shaw145,2500 00For

Institutional-manager reports, all 189 managers: 15,923,459 for, 211,738 against, 8,037 abstained, 60 not voted. Showing the 25 largest; see all in the interactive database.

28. 3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

99.6% Approved · of votes cast

FOR 99.6%
FOR: 30,106,217AGAINST: 92,255
Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 30,106,217 for, 92,255 against — passed, per its Form 8-K filed May 20, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 18,163,270 for, 28,573 against, 14,885 abstained.

FOR
FOR: 18,163,270AGAINST: 28,573ABSTAIN: 14,885
Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accoun” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST2,629,5930 00For
BlackRock2,531,0550 00For
Vanguard2,240,4140 00For
Pacer Funds Trust1,838,1180 00For
Invesco1,252,7230 00For
Capitol Series Trust805,6380 00For
Principal623,0610 00For
MFS563,1560 00For
State Street538,55348 00For
Dimensional475,9000 00For
SEI421,5120 00For
Fidelity342,4920 00For
Federated Hermes316,3010 00For
Charles Schwab313,5300 00For
Victory Capital300,8520 00For
FINANCIAL INVESTORS TRUST290,9780 00For
Royce284,9760 00For
JANUS INVESTMENT FUND272,1830 00For
Prudential/PGIM150,7330 00For
World Funds Trust148,5330 00For
THIRD AVENUE TRUST108,1200 00For
MassMutual102,1370 00For
AllianceBernstein94,7400 00For
MoA Funds Corp92,8020 00For
Columbia Threadneedle89,5660 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

Largest COLLEGIUM PHARMACEUTICAL INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 32,705,747 shares outstanding at the time of that meeting.

Fund voting reports: top COLLEGIUM PHARMACEUTICAL INC. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1MUTUAL FUND SERIES TRUST 8.04%
2BlackRock 7.74%
3Vanguard 6.85%
4Pacer Funds Trust 5.62%
5Invesco 3.83%
6Capitol Series Trust 2.46%
7Principal 1.91%
8MFS 1.72%
9State Street 1.65%
10Dimensional 1.46%
Institutional-manager reports: top COLLEGIUM PHARMACEUTICAL INC. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1Rubric Capital Management LP 3.93%
2State Street 3.74%
3Invesco 2.90%
4BlackRock 2.80%
5PRINCIPAL GLOBAL INVESTORS 2.63%
6Camber Capital Management LP 2.57%
7FULLER & THALER ASSET MANAGEMENT, INC. 2.57%
8MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.02%
9EMERALD MUTUAL FUND ADVISERS TRUST 1.56%
10Victory Capital 1.53%

Reported COLLEGIUM PHARMACEUTICAL INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

COLLEGIUM PHARMACEUTICAL INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 15.83% 13F
Rubric Capital Management LP 8.43% DEF14A
Eventide Asset Management, LLC 8.04% DEF14A
Vanguard Group 6.81% 13F
Principal Global Investors, LLC 5.34% 13G
Invesco 4.99% 13F
Renaissance Technologies 4.34% 13F
State Street 4.03% 13F
Dimensional Fund Advisors 3.12% 13F
Goldman Sachs 2.45% 13F

Percentages above are of 32,705,747 shares outstanding, as reported by COLLEGIUM PHARMACEUTICAL INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from COLLEGIUM PHARMACEUTICAL INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At COLLEGIUM PHARMACEUTICAL INC.'s shareholder meeting held May 16, 2024, in the 2023-2024 proxy season, 260 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,185 separate fund positions. Their filings are grouped here into 28 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval of, on an advisory basis, the compensation of the Company's named executive officers. — COLLEGIUM PHARMACEUTICAL INC.'s filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: COLLEGIUM PHARMACEUTICAL INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 20, 2024.

COLLEGIUM PHARMACEUTICAL INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.